Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases

Neurodegenerative diseases are a spectrum of chronic, debilitating disorders characterised by the progressive degeneration and death of neurons. Mitochondrial dysfunction has been implicated in most neurodegenerative diseases, but in many instances it is unclear whether such dysfunction is a cause or an effect of the underlying pathology, and whether it represents a viable therapeutic target. It is therefore imperative to utilise and optimise cellular models and experimental techniques appropriate to determine the contribution of mitochondrial dysfunction to neurodegenerative disease phenotypes. In this consensus article, we collate details on and discuss pitfalls of existing experimental approaches to assess mitochondrial function in in vitro cellular models of neurodegenerative diseases, including specific protocols for the measurement of oxygen consumption rate in primary neuron cultures, and single-neuron, time-lapse fluorescence imaging of the mitochondrial membrane potential and mitochondrial NAD(P)H. As part of the Cellular Bioenergetics of Neurodegenerative Diseases (CeBioND) consortium ( www.cebiond.org ), we are performing cross-disease analyses to identify common and distinct molecular mechanisms involved in mitochondrial bioenergetic dysfunction in cellular models of Alzheimer's, Parkinson's, and Huntington's diseases. Here we provide detailed guidelines and protocols as standardised across the five collaborating laboratories of the CeBioND consortium, with additional contributions from other experts in the field

In Vivo Fluorescence Imaging of E-Selectin: Quantitative Detection of Endothelial Activation in Arthritis

Rheumatoid arthritis (RA) is a chronic progressive systemic inflammatory disease, characterized by synovial inflammation and localized destruction of cartilage and bone. Heterogeneity in the clinical presentation of RA and uncertainty about which patients will respond to treatment makes diagnosis and management challenging. Fluorescent imaging in the near infrared (NIR) spectrum significantly decreases tissue autofluorescence offering unique potential to detect specific molecular targets in vivo. E-selectin or endothelial adhesion molecule-1 (ELAM-1), a 115kDa glycoprotein induced on endothelial cells in response to pro-inflammatory cytokines involved in RA, such as interleukin (IL)-1 beta and tumour necrosis factor alpha (TNF alpha). E-selectin has been well validated as a potential biomarker of disease activity. My study aimed to investigate whether E-selectin targeted optical imaging in vivo could be developed as a sensitive, specific and quantifiable preclinical molecular imaging technique, and also whether this approach could be used to delineate the molecular effects of novel therapies. I utilised anti-E-selectin antibody labelled with NIR fluorophore in a mouse model of paw swelling induced by intra-plantar injection of TNF alpha, and in acute collagen-induced arthritis (CIA) in DBA/1 mice, a widely used model of RA. E-selectin generated signal, localised to points of maximal clinical inflammation in the inflamed mouse paw in both models with significant differences to control antibody. Binding of anti-E-selectin antibody was also demonstrated by immunohistochemistry in both models. The ability of E-selectin targeted imaging to detect sub-clinical endothelial activation was also investigated, demonstrating that E-selectin may be an excellent way of determining subclinical vascular activation in CIA. Finally the effect of novel targeted therapy – RB200 which blocks epidermal growth factor (EGF) signalling was investigated. This demonstrated that E-selectin targeted signal could be absolutely abrogated to a level seen in unimmunised healthy control animals, following combination treatment with RB200 and the TNF alpha inhibitor etanercept. E-selectin targeted optical imaging is a viable in vivo imaging technique that can also be applied to quantify disease and investigate the effects of novel molecular therapies. It holds significant promise as a molecular imaging technique for future translation into the clinic for patients with rheumatoid arthritis and other inflammatory diseases

Biomedical applications of photochemistry

Photochemistry is the study of photochemical reactions between light and molecules. Recently, there have been increasing interests in using photochemical reactions in the fields of biomaterials and tissue engineering. This work revisits the components and mechanisms of photochemistry and reviews biomedical applications of photochemistry in various disciplines, including oncology, molecular biology, and biosurgery, with particular emphasis on tissue engineering. Finally, potential toxicities and research opportunities in this field are discussed. © 2010 Mary Ann Liebert, Inc.published_or_final_versio

High-Throughput Nonlinear Optical Microscopy

High-resolution microscopy methods based on different nonlinear optical (NLO) contrast mechanisms are finding numerous applications in biology and medicine. While the basic implementations of these microscopy methods are relatively mature, an important direction of continuing technological innovation lies in improving the throughput of these systems. Throughput improvement is expected to be important for studying fast kinetic processes, for enabling clinical diagnosis and treatment, and for extending the field of image informatics. This review will provide an overview of the fundamental limitations on NLO microscopy throughput. We will further cover several important classes of high-throughput NLO microscope designs with discussions on their strengths and weaknesses and their key biomedical applications. Finally, this review will close with a perspective of potential future technological improvements in this field.National Institutes of Health (U.S.) (9P41EB015871-26A1)National Institutes of Health (U.S.) (R01-EX017656)National Institutes of Health (U.S.) (5 R01 NS051320)National Institutes of Health (U.S.) (4R44EB012415-02)National Science Foundation (U.S.) (CBET-0939511)Singapore-MIT AllianceSkolkovo Institute of Science and TechnologySingapore. National Research Foundation (Singapore-MIT Alliance for Research and Technology)Wellcome Trust (London, England) (Massachusetts Institute of Technology. Postdoctoral Fellowship 093831/Z/10/Z

New insights in photodynamic theraphy: production, diffusion and reactivity of singlet oxygen in biological systems

S'ha estudiat la cinètica de fotosensibilització de l'oxigen singlet (1O2) en cèl·lules eucariotes en suspensió mitjançant un espectròmetre d'última generació amb resolució temporal per sota del microsegon. Els estudis revelen que la cinètica del 1O2 depèn del seu lloc de formació. Per una banda, la producció del 1O2 es més lenta en els lisosomes que en el nucli. Per altra banda, el 1O2 es capaç d'escapar de les cèl·lules quan es fotosensibilitza en el nucli, però es queda confinat al interior si es fotosensibilitza en els lisosomes. Malgrat que el temps de vida del 1O2 es troba en els microsegons, la desactivació principal ve donada per interaccions amb les biomolècules característiques de cadascú dels orgànuls. La incertesa respecte a la producció de 1O2 en un orgànul determinat es pot eliminar mitjançant l'ús de fotosensibilitzadors modificats genèticament, ja que aquets poden ésser expressats selectivament. Amb aquesta finalitat, s'avaluen les propietats fotosensibilitzants de mutants de proteïna fluorescent verd (GFP). Algunes de les GFPs estudiades sensibilitzen la formació del 1O2 malgrat amb baixa eficiència. Els resultats obtinguts es comparen amb els del cromòfor de la GFP i mostren que l'estructura proteínica, a sobre de modular les propietats fotofísiques del cromòfor, també el protegeix de la desactivació col·lisional. Finalment, s'estudien les propietats d'absorció bifotónica del 2,7,12,17-tetrafenilporficé i del seu complex de pal·ladi (II). L'eficiència de formació del 1O2 per part dels dos compostos, desprès de l'absorció simultània de dos fotons, es aproximadament 100 vegades superior a la dels seus anàlegs porfirínics, amb seccions d'absorció bifotòniques δ ~ 25 GM. Les excel·lents propietats d'aquestos compostos s'expliquen mitjançant arguments qualitatius i s'analitzen les seves perspectives de cara al seu ús en teràpia fotodinámica.Se ha estudiado la cinética de fotosensibilización de 1O2 en células eucariotas en suspensión, usando un espectrómetro de última generación con resolución temporal por debajo del microsegundo. Los estudios revelan que la cinética del 1O2 depende de su lugar de formación. Por una parte, la producción de 1O2 es más lenta en los lisosomas que en el núcleo. Por otra parte, el 1O2 es capaz de escapar de las células cuando es fotosensibilizado en el núcleo, mientras que queda confinado en el interior si se fotosensibiliza en los lisosomas. A pesar de que el tiempo de vida del 1O2 se encuentra en los microsegundos, la desactivación principal viene dada por interacciones con las biomoléculas características de cada orgánulo. La incertidumbre respecto a la producción de 1O2 en un orgánulo determinado puede ser eliminada mediante el uso de fotosensibilizadores modificados genéticamente ya que pueden ser expresados selectivamente. Con este fin, se evalúan las propiedades fotosensibilizantes de mutantes de proteína fluorescente verde (GFP). Algunas de las GFPs estudiadas sensibilizan la formación de 1O2 aunque con baja eficiencia. Los resultados obtenidos se comparan con los del cromóforo de la GFP y muestran que la estructura proteínica, además de modular las propiedades fotofísicas del cromofóro, también lo protege de la desactivación colisional. Finalmente, se estudian las propiedades de absorción bifotónica del 2,7,12,17-tetrafenilporficeno y de su complejo de paladio (II). La eficacia de formación de 1O2 de ambos compuestos, tras la absorción simultánea de dos fotones, es aproximadamente 100 veces superior a la de sus análogos porfirínicos, con secciones de absorción bifotónica δ ~ 25 GM. Las excelentes propiedades de estos compuestos se explican mediante argumentos cualitativos y se analizan sus perspectivas de cara a su uso en terapia fotodinámica.The kinetics of singlet oxygen (1O2) photosensitisation in human skin fibroblasts have been investigated by means of an ultrasensitive near-infrared spectrometer with submicrosecond time resolution. The results indicate that the 1O2 kinetics are site-dependent. On one hand, the production of 1O2 is slower in the lysosomes than in the nucleus. On the other hand, 1O2 is able to escape out of the cells when photosensitised in the nucleus, while 1O2 photosensitized in the lysosomes is confined. Despite showing a lifetime in the microsecond time domain, the decay of 1O2 is governed by interactions with the biomolecules within the organelle there it is produced. The uncertainty as to the intracellular site of 1O2 production may be removed by the use of genetically-encoded photosensitisers, which can be expressed in any desired organelle. Towards this end, the ability of some fluorescent proteins (GFPs) to photosensitise 1O2 has been studied. Some of the studied proteins are able to produce 1O2 albeit with a very low quantum yield. The results obtained are compared to those of the synthetic GFP chromophore and indicates that the protein scaffold not only plays a role in modulating the photophysical properties of the chromophore but also has a protective function from collisional quenching. Finally, the two-photon absorption properties of tetraphenylporphycene and its palladium (II) complex have been determined. These compounds are ca. 100-fold more efficient two-photon 1O2 photosensitisers than their isomeric porphyrin counterparts, with two-photon absorption cross sections δ ~ 25 GM. Qualitative symmetry-based arguments are provided to explain the excellent two-photon properties and the prospects for photodynamic therapy are discussed

Atrial Natriuretic Peptide Induces Mitogen-Activated Protein Kinase Phosphatase-1 in Human Endothelial Cells via Rac1 and NAD(P)H Oxidase/Nox2-Activation

The cardiovascular hormone atrial natriuretic peptide (ANP) exerts anti-inflammatory effects on tumor necrosis factor-α–activated endothelial cells by inducing mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1). The underlying mechanisms are as yet unknown. We aimed to elucidate the signaling pathways leading to an induction of MKP-1 by ANP in primary human endothelial cells. By using antioxidants, generation of reactive oxygen species (ROS) was shown to be crucially involved in MKP-1 upregulation. ANP was found to increase ROS formation in cultured cells as well as in the endothelium of intact rat lung vessels. We applied NAD(P)H oxidase (Nox) inhibitors (apocynin and gp91ds-tat) and revealed this enzyme complex to be crucial for superoxide generation and MKP-1 expression. Moreover, by performing Nox2/4 antisense experiments, we identified Nox2 as the critically involved Nox homologue. Pull-down assays and confocal microscopy showed that ANP activates the small Rho-GTPase Rac1. Transfection of a dominant-negative (RacN17) and constitutively active Rac1 mutant (RacV12) indicated that ANP-induced superoxide generation and MKP-1 expression are mediated via Rac1 activation. ANP-evoked production of superoxide was found to activate c-Jun N-terminal kinase (JNK). Using specific inhibitors, we linked ANP-induced JNK activation to MKP-1 expression and excluded an involvement of protein kinase C, extracellular signal-regulated kinase, and p38 MAPK. MKP-1 induction was shown to depend on activation of the transcription factor activator protein-1 (AP-1) by using electrophoretic mobility shift assay and AP-1 decoys. In summary, our work provides insights into the mechanisms by which ANP induces MKP-1 and shows that ANP is a novel endogenous activator of endothelial Rac1 and Nox/Nox2

Nonthermal Plasma Technology as a Versatile Strategy for Polymeric Biomaterials Surface Modification: A Review

In modern technology, there is a constant need to solve very complex problems and to fine-tune existing solutions. This is definitely the case in modern medicine with emerging fields such as regenerative medicine and tissue engineering. The problems, which are studied in these fields, set very high demands on the applied materials. In most cases, it is impossible to find a single material that meets all demands such as biocompatibility, mechanical strength, biodegradability (if required), and promotion of cell-adhesion, proliferation, and differentiation. A common strategy to circumvent this problem is the application of composite materials, which combine the properties of the different constituents. Another possible strategy is to selectively modify the surface of a material using different modification techniques. In the past decade, the use of nonthermal plasmas for selective surface modification has been a rapidly growing research field. This will be the highlight of this review. In a first part of this paper, a general introduction in the field of surface engineering will be given. Thereafter, we will focus on plasma-based strategies for surface modification. The purpose of the present review is twofold. First, we wish to provide a tutorial-type review that allows a fast introduction for researchers into the field. Second, we aim to give a comprehensive overview of recent work on surface modification of polymeric biomaterials, with a focus on plasma-based strategies. Some recent trends will be exemplified. On the basis of this literature study, we will conclude with some future trends for research

Multiscale approach predictions for biological outcomes in ion-beam cancer therapy

10 págs.; 4 figs. 1 tab. ; Open Access funded by Creative Commons Atribution Licence 4.0Ion-beam therapy provides advances in cancer treatment, offering the possibility of excellent dose localization and thus maximising cell-killing within the tumour. The full potential of such therapy can only be realised if the fundamental mechanisms leading to lethal cell damage under ion irradiation are well understood. The key question is whether it is possible to quantitatively predict macroscopic biological effects caused by ion radiation on the basis of physical and chemical effects related to the ion-medium interactions on a nanometre scale. We demonstrate that the phenomenon-based MultiScale Approach to the assessment of radiation damage with ions gives a positive answer to this question. We apply this approach to numerous experiments where survival curves were obtained for different cell lines and conditions. Contrary to other, in essence empirical methods for evaluation of macroscopic effects of ionising radiation, the MultiScale Approach predicts the biodamage based on the physical effects related to ionisation of the medium, transport of secondary particles, chemical interactions, thermo-mechanical pathways of biodamage, and heuristic biological criteria for cell survival. We anticipate this method to give great impetus to the practical improvement of ion-beam cancer therapy and the development of more efficient treatment protocols.We acknowledge the financial support received from the European Union Seventh Framework Programme (PEOPLE2013-ITN-ARGENT project) under grant agreement no. 608163.Peer Reviewe